MedTrace Logo

Study of Blood Samples in Patients With Breast Cancer

NCT00959556 · Status: COMPLETED · Type: OBSERVATIONAL

Last updated 2026-03-18

No results posted yet for this study

Summary

RATIONALE: Studying the genes expressed in samples of blood from patients with cancer may help doctors identify biomarkers related to cancer. It may also help doctors predict how patients will respond to chemotherapy.

PURPOSE: This clinical trial is studying blood samples in patients with breast cancer.

Conditions

Interventions

OTHER

laboratory biomarker analysis

Sponsors & Collaborators

  • Centre Oscar Lambret

    lead OTHER

Principal Investigators

  • Jacques Bonneterre, MD, PhD · Centre Oscar Lambret

Eligibility

Min Age
18 Years
Max Age
120 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-11-28
Primary Completion
2012-01-06
Completion
2012-01-06

Countries

  • France

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00959556 on ClinicalTrials.gov